Identification of HIF-dependent alternative splicing in gastrointestinal cancers and characterization of a long, coding isoform of SLC35A3

Genomics. 2021 Mar;113(2):515-529. doi: 10.1016/j.ygeno.2020.12.039. Epub 2021 Jan 5.

Abstract

Intra-tumor hypoxia is a common feature in many solid cancers. Although transcriptional targets of hypoxia-inducible factors (HIFs) have been well characterized, alternative splicing or processing of pre-mRNA transcripts which occurs during hypoxia and subsequent HIF stabilization is much less understood. Here, we identify many HIF-dependent alternative splicing events after whole transcriptome sequencing in pancreatic cancer cells exposed to hypoxia with and without downregulation of the aryl hydrocarbon receptor nuclear translocator (ARNT), a protein required for HIFs to form a transcriptionally active dimer. We correlate the discovered hypoxia-driven events with available sequencing data from pan-cancer TCGA patient cohorts to select a narrow set of putative biologically relevant splice events for experimental validation. We validate a small set of candidate HIF-dependent alternative splicing events in multiple human gastrointestinal cancer cell lines as well as patient-derived human pancreatic cancer organoids. Lastly, we report the discovery of a HIF-dependent mechanism to produce a hypoxia-dependent, long and coding isoform of the UDP-N-acetylglucosamine transporter SLC35A3.

Keywords: Alternative splicing; Cancer isoforms; Hypoxia; Metabolism; SLC35A3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing*
  • Aryl Hydrocarbon Receptor Nuclear Translocator / genetics
  • Aryl Hydrocarbon Receptor Nuclear Translocator / metabolism
  • Cell Line, Tumor
  • Gastrointestinal Neoplasms* / genetics
  • Gastrointestinal Neoplasms* / metabolism
  • Humans
  • Hypoxia-Inducible Factor 1 / metabolism
  • Transcriptome
  • Tumor Hypoxia

Substances

  • ARNT protein, human
  • Aryl Hydrocarbon Receptor Nuclear Translocator
  • Hypoxia-Inducible Factor 1
  • SLC35A3 protein, human